Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Company Statementmore...
Biocon Limited has informed the Exchange regarding Company Statement .more...
Certificate pursuant to SEBI Master Circular dated October 15 2025more...
Biocon Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Biocon Limited has informed the Exchange about Schedule of meetmore...
Intimation of Earnings Conference Call for Analysts and Investorsmore...
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve In...more...
As of March 2026 44.91% is owned by Promoters 55.00% by Public and 0.09% by Non Promoters-Non Public. Among Promoters holding Indian Promote...more...
Biocon Limited has received approval from Health Canada for its denosumab biosimilars Bosaya and Vevzuo marking a key milestone in its global expansi...more...
Biocon Limited has informed the Exchange regarding a press release dated April 21 2026 titled Biocon Receives Health Canada Approval of Bosa...more...
Press Releasemore...
Biocon Limited has informed the Exchange about Reminder Letter to shareholders holding shares in physical form for furnishing of KYC detailsmore...
Reminder Letter to shareholders holding shares in physical form for furnishing KYC detailsmore...
Biocon Ltd on Wednesday announced that its subsidiary Biocon Pharma Ltd has received approval from the US Food and Drug Administration for i...more...
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)more...
Biocon Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Biocon Limited has informed the Exchange regarding a press release dated April 07 2026 titled Biocon Announces U.S. Commercial Launch of Bos...more...
BOARD MEETINGS Company Name : Paisalo Digital Date : 10-05-2026